Addressing Drop Adherence

Show Description +

I. Paul Singh, MD, describes the use of iStent Infinite (Glaukos) and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) to help reduce the drop burden for this patient.

Financial disclosure: Consultant (Glaukos)

Posted: 1/02/2024

Addressing Drop Adherence

I. Paul Singh, MD, describes the use of iStent Infinite (Glaukos) and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) to help reduce the drop burden for this patient.

Financial disclosure: Consultant (Glaukos)

Posted: 1/02/2024

Please log in to leave a comment.

More in Glaucoma

Implementing Interventional Glaucoma Treatment Protocols

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Treatment Patterns and Patient Compliance

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; and Deborah Ristvedt, DO

Practice Assessment Results

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

The Unmet Need for a Consensus Treatment Approach to Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD